The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Fabrication and characterization of silk fibroin-derived curcumin nanoparticles for cancer therapy
Open accessAbstract
Biologically derived nanoparticles (<100 nm) were fabricated for local and sustained therapeutic curcumin delivery to cancer cells. Silk fibroin (SF) and chitosan (CS) polymers were blended noncovalently to encapsulate curcumin in various proportions of SF and CS (75:25, 50:50, and 25:75 SF:CS) or pure SF at two concentrations (0.1% w/v and 10% w/v) using the devised capillary-microdot technique. Curcumin-polymer conjugates were frozen, lyophilized, crystallized, suspended in phosphate-buffered saline for characterization, and tested for efficacy against breast cancer cells. All nanoparticle formulations except 0.1% w/v 50:50 SFCS were less than 100 nm in size as determined with the transmission electron microscopy. The entrapment and release of curcumin over eight days was highest for SF-derived nanoparticles as compared to all SFCS blends. The uptake and efficacy of SF-coated curcumin was significantly higher (p < 0.001) than SFCS-coated curcumin in both low and high Her2/neu expressing breast cancer cells. Interestingly, the uptake of curcumin was highest for the high Her2/neu expressing breast cancer cells when delivered with a 10% w/v SF coating as compared to other formulations. In conclusion, SF-derived curcumin nanoparticles show higher efficacy against breast cancer cells and have the potential to treat in vivo breast tumors by local, sustained, and long-term therapeutic delivery as a biodegradable system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bioavailability of curcumin: Problems and promises
Anand, P., Kunnumakkara, A. B., Newman, R. A., & Aggarwal, B. B. (2007) · Molecular Pharmaceutics · doi:10.1021/mp700113r · Cited by 5,543
Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC)
Siepmann, J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00112-0 · Cited by 2,613
Bisht, S., Feldmann, G., Soni, S., Ravi, R., Karikar, C., Maitra, A., & Maitra, A. (2007) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-5-3 · Cited by 1,090
Kunnumakkara, A. B., Anand, P., & Aggarwal, B. B. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.009 · Cited by 1,073
Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC)
Siepmann, J., & Peppas, N. A. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.028 · Cited by 1,021
Li, L., Braiteh, F. S., & Kurzrock, R. (2005) · Cancer · doi:10.1002/cncr.21300 · Cited by 644
Aggarwal, B. B., Shishodia, S., Takada, Y., Banerjee, S., Newman, R. A., Bueso-Ramos, C. E., & Price, J. E. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1192 · Cited by 584
Formulation and characterization of curcuminoids loaded solid lipid nanoparticles
Tiyaboonchai, W., Tungpradit, W., & Plianbangchang, P. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.12.043 · Cited by 410
Silk microspheres for encapsulation and controlled release
Wang, X., Wenk, E., Matsumoto, A., Meinel, L., Li, C., & Kaplan, D. L. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.11.021 · Cited by 293
Kunwar, A., Barik, A., Pandey, R., & Priyadarsini, K. I. (2006) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2006.06.012 · Cited by 286
Silk fibroin spheres as a platform for controlled drug delivery
Wenk, E., Wandrey, A. J., Merkle, H. P., & Meinel, L. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.08.005 · Cited by 271
Sahu, A., Bora, U., Kasoju, N., & Goswami, P. (2008) · Acta Biomaterialia · doi:10.1016/j.actbio.2008.04.021 · Cited by 239
Loading of curcumin into macrophages using lipid-based nanoparticles
Sou, K., Inenaga, S., Takeoka, S., & Tsuchida, E. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.10.033 · Cited by 185
Nanolayer biomaterial coatings of silk fibroin for controlled release
Wang, X., Hu, X., Daley, A., Rabotyagova, O., Cebe, P., & Kaplan, D. L. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.06.006 · Cited by 184
Curcumin inhibits tyrosine kinase activity of p185neu and also depletes p185neu.
Hong, R. L., Spohn, W. H., & Hung, M. (1999) · PubMed · Cited by 161
Gobin, A. S., Froude, V. E., & Mathur, A. B. (2005) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.30382 · Cited by 158
Gobin, A. S., Butler, C. E., & Mathur, A. B. (2006) · Tissue Engineering · doi:10.1089/ten.2006.12.3383 · Cited by 121
Silk-fibroin-coated liposomes for long-term and targeted drug delivery
Gobin, A. S., Rhea, R., Newman, R. A., & Mathur, A. B. (2006) · International Journal of Nanomedicine · doi:10.2147/nano.2006.1.1.81 · Cited by 98
Silk fibroin mediated delivery of liposomal emodin to breast cancer cells
Cheema, S. K., Gobin, A. S., Rhea, R., Lopez‐Berestein, G., Newman, R. A., & Mathur, A. B. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.03.043 · Cited by 78
Gobin, A. S., Butler, C. E., & Mathur, A. B. (2006) · Tissue Engineering · doi:10.1089/ten.2006.12.ft-285 · Cited by 7
Cited by
Curcumin Nanoparticles: Preparation, Characterization, and Antimicrobial Study
Bhawana, Basniwal, R. K., Buttar, H. S., Jain, V. K., & Jain, N. (2011) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf104402t · Cited by 863
Protein-based nanocarriers as promising drug and gene delivery systems
Elzoghby, A. O., Samy, W. M., & Elgindy, N. A. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.04.036 · Cited by 852
The Biomedical Use of Silk: Past, Present, Future
Holland, C., Numata, K., Rnjak‐Kovacina, J., & Seib, F. P. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201800465 · Cited by 815
Curcumin nanoformulations: a future nanomedicine for cancer
Yallapu, M. M., Jaggi, M., & Chauhan, S. C. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2011.09.009 · Cited by 751
Biopolymer-Based Nanoparticles for Drug/Gene Delivery and Tissue Engineering
Nitta, S., & Numata, K. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14011629 · Cited by 666
Metadata
- Authors
- Gupta, V.
- Venue
- International Journal of Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2009-05
- Volume
- 4
- Pages
- 115
- ISSN
- 1176-9114 (ISSN-L)
- 1178-2013
- OpenAlex
- W2145562853
- Cited by
- 282
- References
- 20
- FWCI
- 4.79
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.